About Careers MedBlog Contact us

Gastrointestinal Stromal Tumors may Lead to Cancers Outside Their Syndromes

by Dr. Trupti Shirole on May 4, 2015 at 7:45 AM
Font : A-A+

Gastrointestinal Stromal Tumors may Lead to Cancers Outside Their Syndromes

Patients suffering from gastrointestinal tumors are at increased risk of contracting other cancers, revealed a study. The results indicated that one in 5.8 patients with gastrointestinal stromal tumors (GIST) will develop additional malignancies before and after their diagnosis. Specifically, patients with GIST are more likely to develop other sarcomas, non-Hodgkin's lymphoma, carcinoid tumors, melanoma, colorectal, esophageal, pancreatic, hepatobiliary, prostate and renal cell cancers.

Jason Sicklick, assistant professor of surgery at the University of California's San Diego School of Medicine, said, "The research indicates that these patients may develop cancers outside these syndromes but the exact mechanisms are not yet known. Only 5% of patients with gastrointestinal stromal tumors have a hereditary disorder that predisposes them to develop multiple benign and malignant tumors. Further studies are needed to understand the connection between GIST and other cancers."


When compared to the United States population, the researchers found that people with GIST had a 44% increased prevalence of cancers occurring before a GIST diagnosis and a 66% higher risk of developing cancers after diagnosis. The most common tumors were those of the genitourinary tract, breast, respiratory and blood.

Co-author James Murphy from the University of California said, "Patients diagnosed with gastrointestinal stromal tumours may warrant consideration for additional screenings based on the other cancers that they are most susceptible to contract."

The study is published in Cancer.

Source: Medindia


Recommended Reading

Latest Cancer News

Could TKI Cancer Drugs Lead to Inflammatory Side Effects?
The mechanism by which the kinases cause inflammation has been discovered by scientists.
Are Biomarkers the Key to Identifying Early Pancreatic Risk?
Pancreatic cancer cases are on the rise. The biomarker approach could reduce the chance of developing pancreatic cancer.
How Does New Drugs Work Together to Reduce Lung Tumors?
New combination of medications trametinib and entinostat were found to decrease lung cancer in mice.
New Combination Therapy Proves Effective Against Prostate Cancer
Combination treatment with TALZENNA and XTANDI was found to benefit prostate cancer patients, revealed study.
Can Vitamin A Rich Diet Help Reduce Pancreatitis Risk
In leukemia patients, reduced amounts of dietary vitamin A is associated with a higher risk and severity of pancreatitis.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Gastrointestinal Stromal Tumors may Lead to Cancers Outside Their Syndromes Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests